- Vallexa Advisors

Selling Your Hospice in 2026: What the Crackdown Means for Valuation, Exit & Buyer Demand

Federal regulators just suspended Medicare payments to 447 hospices and 23 home health organizations over $600M+ in alleged fraudulent billing. For clean hospice owners weighing a sale, this is the strongest seller’s market in five years — but only if your books, compliance file, and process are ready. Here’s what your hospice is worth in 2026, how the buyer landscape has shifted, and the 7-step confidential sale process Vallexa Advisors runs for every hospice client.

2026 hospice and home health valuation multiples report showing EBITDA trends across the U.S. market

2026 Hospice & Home Health Valuation Multiples Report (US Market)

A 2026 analysis of hospice and home health valuation multiples across the U.S. market. This report breaks down EBITDA multiples, explains how revenue ties into valuation, compares hospice vs home health trends, and outlines what buyers and sellers need to know in 2026.

Hospice valuation guide checklist showing steps to prepare financials, compliance documentation, referrals, and data room for a higher multiple.

A Hospice Owner’s Guide to Valuation Multiples: What Drives Price, How to Prepare, and How to Avoid Exit Pitfalls (U.S.)

A step-by-step hospice owner’s guide to valuation multiples: how buyers think, what to prepare, how to avoid exit pitfalls, and protect your sale price.

Hospice M&A rebounds with strongest quarter since 2021, highlighting hospice valuation trends and buyer demand for quality agencies

Hospice M&A Rebounds: What the “Strongest Quarter Since 2021” Means for Hospice Owners Considering a Sale

Hospice M&A surged in late 2025, marking the strongest quarter since 2021. Learn what this means for hospice valuation, buyer demand, and selling strategy.

home health valuation, home care valuation, hospice valuation, how much is my home health worth, sell my home health agency, selling a home care business, home health agency value, CMS team model, MedPAC 7 percent cut, home health payment cuts, healthcare M&A, healthcare mergers and acquisitions advisors, PDGM valuation impact, home health compliance, selling a healthcare business, home health due diligence, agency exit planning, valuation multiples home health, healthcare business brokers, Vallexa Advisors

What the New CMS Rules Mean for Home Health Providers — And How They Impact Your Agency’s Valuation in 2026 & Beyond

Home health and hospice owners are facing major CMS changes—from the new Team Model to MedPAC’s proposed 7% payment cut. These shifts directly influence valuation, buyer appetite, and the timing of your exit. Learn how these rules affect what your agency is worth, what buyers look for now, and how to protect your value before selling.

Smiling home health nurse with elderly patient on a Mid-Atlantic coastal boardwalk, promoting a Medicare-certified home health agency for sale in Virginia.

Virginia Medicare Home Health Agency For Sale

Mid-Atlantic Medicare-certified home health agency based in Virginia, offering a full continuum of skilled services and supported by bilingual clinical staff. Includes 2 home health PTANs and 1 hospice first license, Joint Commission and ACHC accreditation, and FY-2024 revenue of approximately $2.38M with strong margins. Accepting market offers. Ref #8106576234.

Vallexa Advisors helping buyers and sellers navigate home health and hospice mergers and acquisitions with a global healthcare focus

Sell or Buy a Home Health Care Business: Your 2026 Guide

Discover how Vallexa Advisors is redefining hospice and healthcare valuations with precision, global reach, and integrity. Whether you’re selling a hospice, home health, or senior-care business, our team helps you navigate the complexities of valuation, compliance, and buyer negotiations — ensuring you achieve maximum value for your legacy.

Professional Vallexa Advisors banner showcasing global healthcare M&A expertise with a blue networked globe symbolizing connection, trust, and growth.

Hospice Valuation amid Fraud Crackdowns, Shutdowns & Policy Shifts: What Owners Need to Know

Illustration showing healthcare professionals and hospice valuation metrics, representing Vallexa Advisors’ expert guide on maximizing hospice agency value.

Hospice Valuation: Understanding the Process and Maximizing Your Agency’s Worth

Discover how hospice valuations are determined and what truly drives your agency’s worth. Learn the factors buyers consider — from EBITDA to compliance — and how Vallexa Advisors helps hospice owners secure premium valuations through expert guidance, national reach, and success-only fees.

Home care agency for sale in Central Pennsylvania’s Region 5. State licensed, Medicaid certified, established 2023. Provides non‑medical services and eligible for MCO contracts. Serves ten counties. Cash sale only; $80K (Ref #9385647852).

Home Care Agency for Sale in Pennsylvania

Turnkey non‑medical home care agency for sale in Central Pennsylvania (Region 5). State‑licensed and Medicaid‑certified, established in 2023, serving ten counties. Eligible for MCO applications. Cash sale only at $80,000 (Ref #9385647852) – an excellent opportunity for experienced home health operators.

Vallexa Advisors

Leaders in Healthcare Mergers & Acquisitions

Tag: healthcare M&A